Collectively, this retrospective study demonstrated that pretherapeutic sIL-8 level is associated with LNM and tumor recurrence, and may act as a potential tumor marker in gastric cancer, especially in patients with negative CEA. This evidence concerns the gene CEACAM5 and gastric cancer.